GXP

Quality and Compliance in the Asian Pharmaceutical Industry | IVT

Introduction The Asian pharmaceutical manufacturing industry is becoming more complex, with some Asian countries moving more aggressively than others to supply their to regulated markets such as the US and Europe. Emerging markets, poised to account for about 45% of the world’s gross domestic profit by 2018, are projected to represent the majority of growth in pharmaceutical sales in the next five years (1). According to a recent report, in 2008, the global active pharmaceutical ingredients’ (APIs) market (including both captive and merchant) worth was $91 billion; it increased to $113 billion...

This content is only available to IVT members.
Get help maintaining your knowledge in GMP - Compliance & Regulations. Read More!

If you are already a member and you do not have access to this article, upgrade your membership.
Need help? Read our FAQs.




Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.